| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions |
5U01CA274514-02 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs |
5U2CCA271895-02 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Chan, Andrew T |
Massachusetts General Hospital
United States |
MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors |
1OT2CA297680-01 |
|
Asad Umar, D.V.M., Ph.D. |
| Chan, Alexandre |
University Of California-Irvine
United States |
Neurotrophic strategy to mitigate chemotherapy-related brain injury |
5R01CA276212-02 |
PAR-21-329 (R01 Clinical Trial Optional) |
Catherine Schweppe, Ph.D. |
| Chan, Andrew T |
Massachusetts General Hospital
United States |
Precision Prevention Research Program |
5R35CA253185-05 |
|
Asad Umar, D.V.M., Ph.D. |
| Chang, Su-Hsin |
Washington University
United States |
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective |
5R01CA253475-03 |
|
Asad Umar, D.V.M., Ph.D. |
| Chapkin, Robert Stephen |
Texas A&M Agrilife Research
United States |
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling |
5R01CA244359-05 |
|
Amit Kumar, Ph.D. |
| Chen, Grace Y. |
University Of Michigan At Ann Arbor
United States |
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention |
5R21CA273646-02 |
|
Winfred Malone, Ph.D., M.P.H. |
| Chen, Ru |
Baylor College Of Medicine
United States |
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION |
1UH2CA292130-01 |
|
Claire Zhu, Ph.D. |
| Cheville, Andrea Lynne |
Mayo Clinic Rochester
United States |
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial |
5R33CA278594-03 |
|
Brennan Streck, Ph.D., RN, M.P.H. |